Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Dedifferentiated Liposarcoma of the Retroperitoneum

Kim ES, Jang SH, Park HC, Jung EH, Moon GB

  • Cancer Res Treat.
  • 2010 Mar;42(1):57-60.
A dedifferentiated liposarcoma of the retroperitoneum is an extremely rare tumor. A 51-year old man was admitted to our department because a retroperitoneal mass was seen on abdominal computed tomography...
A Case of Synchronous Double Primary Cancer of the Penis and Urinary Bladder

Cho YS, Lee JA, Kim SB, Gong SJ, Kim JH, Youn SM, Kim ET

  • Cancer Res Treat.
  • 2010 Mar;42(1):53-56.
Multiple primary cancers are the occurrence of more than two cancers of different origin in an individual. Penile cancer is a rare disease, and finding it combined with other cancers...
Diagnostic Laparoscopy of Patient with Deep Vein Thrombosis before Diagnosis of Ovarian Cancer: A Case Report

Ha JE, Lee YS, Lee HN, Park EK

  • Cancer Res Treat.
  • 2010 Mar;42(1):48-52.
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Epidemiological studies have demonstrated an increased risk of subsequent cancer in the patients who are diagnosed with idiopathic...
Maspin Suppresses Survival of Lung Cancer Cells through Modulation of Akt Pathway

Nam E, Park C

  • Cancer Res Treat.
  • 2010 Mar;42(1):42-47.
PURPOSE: Maspin is a tumor suppressor protein that has been reported to stimulate the cell death of cancer and inhibit the metastasis of cancer. The present study aimed to explore...
Coexisting with Clonal Evolution and BCR-ABL Mutant in CML Patients Treated with Second-generation Tyrosine Kinase Inhibitors Predict the Discrepancy of in vitro Drug Sensitivity

Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ

  • Cancer Res Treat.
  • 2010 Mar;42(1):37-41.
PURPOSE: Second-generation tyrosine kinase inhibitors (second TKIs) such as nilotinib and dasatinib control the activity of most ABL kinase domain mutations observed in patients with imatinib resistance. Although in vitro...
Predictors of Axillary Lymph Node Metastases (ALNM) in a Korean Population with T1-2 Breast Carcinoma: Triple Negative Breast Cancer has a High Incidence of ALNM Irrespective of the Tumor Size

Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK

  • Cancer Res Treat.
  • 2010 Mar;42(1):30-36.
PURPOSE: We estimated the likelihood of breast cancer patients having axillary lymph node metastases (ALNM) based on a variety of clinical and pathologic factors. MATERIALS AND METHODS: Three hundred sixty-one...
Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric Cancer

Kim YS, Hong J, Sym SJ, Park SH, Park J, Cho EK, Lee JH, Shin DB

  • Cancer Res Treat.
  • 2010 Mar;42(1):24-29.
PURPOSE: This study was designed to determine the efficacy and safety of FOLFOX-4 chemotherapy as a salvage treatment for patients with advanced gastric cancer (AGC). MATERIALS AND METHODS: The AGC...
Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis

Lee HH, Hur H, Kim SH, Park AR, Kim W, Jeon HM

  • Cancer Res Treat.
  • 2010 Mar;42(1):18-23.
PURPOSE: Treatment options for patients with advanced gastric cancer remain limited. Few studies have investigated the efficacy and tolerability of the combination regimen of oxaliplatin and 5-fluorouracil with leucovorin for...
Efficacy and Safety of Docetaxel Plus Prednisolone Chemotherapy for Metastatic Hormone-Refractory Prostate Adenocarcinoma: Single Institutional Study in Korea

Lee JL, Kim JE, Ahn JH, Lee DH, Lee J, Kim CS, Hong JH, Hong B, Song C, Ahn H

  • Cancer Res Treat.
  • 2010 Mar;42(1):12-17.
PURPOSE: To assess the efficacy and safety of treating Korean patients with metastatic hormone-refractory prostate cancer (HRPC) using docetaxel plus prednisolone chemotherapy. MATERIALS AND METHODS: This was a retrospective cohort...
Salvage Radiotherapy for Patients with PSA Relapse Following Radical Prostatectomy: Issues and Challenges

Choo R

  • Cancer Res Treat.
  • 2010 Mar;42(1):1-11.
A progressively rising level of serum prostate specific antigen (PSA) after radical prostatectomy (RP) invariably indicates the recurrence of prostate cancer. The optimal management of patients with post-RP PSA relapse...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr